Risk factors for developing pacing induced LV dysfunction: Experience from a tertiary center in the UK. Issue 3 (28th January 2022)

• Record Type: Journal Article
• Authors: Kanthasamy, Vijayabharathy; Papageorgiou, Nikolaos; Bajomo, Tomi; Monkhouse, Christopher; Creta, Antonio; Finlay, Malcolm; Lambiase, Pier D; Moore, Phil; Sporton, Simon; Earley, Mark J.; Schilling, Richard J.; Hayward, Carl; Providência, Rui; Hunter, Ross J.; Chow, Anthony W.; Muthumala, Amal
• Is Part Of: Pacing and clinical electrophysiology. Volume 45:Issue 3(2022)
• Page Start: 365
• Page End: 373
• Publication Date: 2022-01-28
• Subjects: heart failure -- left ventricular dysfunction -- pacemaker -- pacing induced left ventricular dysfunction -- right ventricular pacing; Cardiac pacing -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1111/pace.14442
• Languages: English
• ISSNs: 0147-8389

Abstract

Abstract: Background: The risk factors for developing pacing induced left ventricular dysfunction (LVD) in patients with high burden of right ventricular pacing (RVP) is poorly understood. Therefore, in the present study, we aimed to assess the determinants of pacing induced LVD. Methods: Our data were retrospectively collected from 146 patients with RVP > 40% who underwent generator change (GC) or cardiac resynchronization therapy (CRT) upgrade between 2016 and 2019 who had left ventricular ejection fraction (EF) ≥50% at initial implant. Results: A total of 75 patients had CRT upgrade due to pacing induced LVD (EF < 50%) and 71 patients with preserved LV function (EF ≥ 50%) had a GC. Primary indication for pacing in both groups was complete heart block. Male predominance ( p = .008), prior myocardial infarction (MI) ( p = .001), atrial fibrillation (AF) ( p = .009), chronic kidney disease (CKD) ( p = .005), and borderline low systolic function (BLSF) (EF 50%–55%) ( p = .04) were more prevalent in the CRT upgrade group. Presence of AF (odds ratio [OR] = 3.05, 95% confidence interval [CI] 1.42–6.58; p = .004), BLSF (OR = 3.8, 95% CI 1.22–11.8; p = .02), and male gender (OR = 2.41, 95% CI 1.14–5.08; p = .02) were independent predictors for RVP induced LVD. Age (OR = 1.08, 95% CI 1.02–1.14; p = .005) and BLSF (OR = 5.33, 95% CI 1.26–22.5; p = .023) were independent predictors of earlier development of LVD after implant. Conclusions: Our results suggested that AF, BLSF, and male gender are predictors for development of pacing induced LVD in patients with high RVP burden. LVD can occur at any time after pacemaker implant with BLSF and increasing age associated with earlier development of LVD.